ENvue Medical Inc(FEED) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -265.7 | Insider Own | 6.98% | Shs Outstand | 0.9M | Perf Week | -71.23% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | -76.54% | Shs Float | 0.9M | Perf Month | -79.74% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 2.62% | Short Float | 0.85% | Perf Quarter | -87.22% |
| Income | -0.05B | P/S | 0.49 | EPS this Y | - | Inst Trans | - | Short Ratio | 0.08 | Perf Half Y | -92.91% |
| Sales | 0.00B | P/B | 0.02 | EPS next 5Y | - | ROA | -100.9% | Short Interest | 0.01M | Perf YTD | -96.28% |
| Book/sh | 45.04 | P/C | 0.83 | EPS past 3/5Y | 60.16% 50.78% | ROE | -127.32% | 52W High | -99.07% ($110.97) | Perf Year | -99.2% |
| Cash/sh | 1.24 | P/FCF | - | Sales past 3/5Y | 50.29% 32.59% | ROIC | -147.11% | 52W Low | 22.62% ($0.84) | Perf 3Y | -99.97% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 83.53% | Gross Margin | -26.06% | Volatility(W/M) | 68.69% 24.37% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | 0.58 | Sales Y/Y TTM | -17.66% | Oper. Margin | -783.59% | ATR (14) | 0.62 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 0.31 | EPS Q/Q | 80.85% | Profit Margin | -2553.89% | RSI (14) | 17.47 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.66 | Sales Q/Q | -51.62% | SMA20 | -74.92% ($4.11) | Beta | 1.44 | Target Price | $10.5 |
| Payout | - | Debt/Eq | 0.04 | Earnings | - | SMA50 | -77.44% ($4.57) | Rel Volume | 0 | Prev Close | $1.03 |
| Employees | 14 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -94.43% ($18.49) | Avg Volume(3M) | 0.09M | Price | $1.03 |
| IPO | 2015/5/28 | Option/Short | No/Yes | Trades | 0 | Volume | - | Change | - |
🩺 ENvue Medical () is a U.S. medical device company that develops and sells electromagnetic navigation medical devices designed to help safely insert feeding tubes for delivering nutrition to a patient's stomach or small intestine. The company was formerly known as NanoVibronix but changed its name and ticker to emphasize its core business, the ENvue navigation platform. It is a micro-cap stock with a small market capitalization.
Over the past 1 year, on the lower side
99% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
FEED has weak earnings and a weak balance sheet
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $49. Peers typically go for $145.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -100.0%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 2.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
VXF Vanguard Extended Market Index ETF <0.01% It ranks #142 of 143 in the industry
Based on market cap of $1M.
XAIR#139 Beyond Air Inc $2M PER - 
NUWE#140 Nuwellis Inc $2M PER - 
GCTK#141 GlucoTrack Inc $2M PER - FEED#142 ENvue Medical Inc $1M PER - 
PFSA#142 Profusa Inc $1M PER - 
FAQ
What kind of company is FEED?
FEED belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of FEED?
The market cap of FEED is approximately $1M, ranking 5,897 within its sector.
What is the 52-week high and low for FEED?
FEED has recorded a 52-week high of $110.97 and a low of $0.84.
